Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy
Archives of Otolaryngology, 09/02/09
Snitcovsky I et al. – In patients with HNSCC undergoing chemoradiotherapy, a low pre-treatment plasma OPN level is associated with tx response and better survival.
Methods- Prospective study
- Plasma OPN levels before and within 12 weeks after tx in 69 patients with HNSCC undergoing platinum-based chemoradiotherapy
- Pre-treatment OPN levels were higher in patients with advanced T and N stagesw compared with patients with early stages
- Pre-treatment and post-treatment levels of OPN were lower in patients who achieved a CR compared with those who failed to respond (75.0 vs. 131.2 ng/ml) and (86.8 vs. 141.6 ng/ml)
- Patients with high tre-treatment OPN levels had shorter survival time
Related Articles
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 84%
Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 83%
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 83%
Clinical Features and Short-Term Outcome of Critically Ill Patients With Head and Neck Cancer in the Medical Intensive Care Unit
American Journal of Clinical Oncology, 10/07/09
Relevance Score: 83%
Sheddase Activity of Tumor Necrosis Factor-alpha Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 82%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers
Journal of Clinical Oncology, 12/10/09
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 12/10/09
Association of BRCA1 mutations with occult primary ovarian insufficiency: A possible explanation for the link between infertility and breast/ovarian cancer risks
Journal of Clinical Oncology, 12/10/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
British Journal of Cancer, 12/10/09
Human papillomavirus infection and squamous cell carcinoma of the conjunctiva
British Journal of Cancer, 12/10/09
Effects of functional electrical stimulation on dysphagia caused by radiation therapy in patients with nasopharyngeal carcinoma
Supportive Care in Cancer, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


